A G Engel|E H Lambert - JoVE Visualize

Showing results (171-180 of 212) with videos related to

Pageof 22

Sort By:

Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1997

A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravisH Yoshikawa, E H Lambert, D R Walser-Kuntz, et al.

Annals of Neurology|October 1, 1979

Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basisP J Dyck, J A Carney, G W Sizemore, et al.

Neuron|July 1, 1995

Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinityS M Sine, K Ohno, C Bouzat, et al.

Human Molecular Genetics|December 1, 1994

Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutationM L Huie, A S Chen, S Tsujino, et al.

Journal of Neuropathology and Experimental Neurology|November 1, 1980

Structural and biochemical effects of essential fatty acid deficiency on peripheral nerveB A Evans, J K Yao, R T Holman, et al.

Annals of Neurology|June 1, 1996

MELAS- and Kearns-Sayre-type co-mutation [corrected] with myopathy and autoimmune polyendocrinopathyK Ohno, M Yamamoto, A G Engel, et al.

Neurology|July 1, 1981

Primary systemic carnitine deficiency. II. Renal handling of carnitineA G Engel, C J Rebouche, D M Wilson, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 31, 1995

Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunitK Ohno, D O Hutchinson, M Milone, et al.

Neurology|January 1, 1975

The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic featuresG Karpati, S Carpenter, A G Engel, et al.

Muscle & Nerve|January 1, 1996

A transgenic mouse model of the slow-channel syndromeC M Gomez, B B Bhattacharyya, P Charnet, et al.

Pageof 22

Showing results (171-180 of 212) with videos related to

Sort By:

Pageof 22

Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1997

A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravisH Yoshikawa, E H Lambert, D R Walser-Kuntz, et al.

Annals of Neurology|October 1, 1979

Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basisP J Dyck, J A Carney, G W Sizemore, et al.

Neuron|July 1, 1995

Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinityS M Sine, K Ohno, C Bouzat, et al.

Human Molecular Genetics|December 1, 1994

Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutationM L Huie, A S Chen, S Tsujino, et al.

Journal of Neuropathology and Experimental Neurology|November 1, 1980

Structural and biochemical effects of essential fatty acid deficiency on peripheral nerveB A Evans, J K Yao, R T Holman, et al.

Annals of Neurology|June 1, 1996

MELAS- and Kearns-Sayre-type co-mutation [corrected] with myopathy and autoimmune polyendocrinopathyK Ohno, M Yamamoto, A G Engel, et al.

Neurology|July 1, 1981

Primary systemic carnitine deficiency. II. Renal handling of carnitineA G Engel, C J Rebouche, D M Wilson, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 31, 1995

Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunitK Ohno, D O Hutchinson, M Milone, et al.

Neurology|January 1, 1975

The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic featuresG Karpati, S Carpenter, A G Engel, et al.

Muscle & Nerve|January 1, 1996

A transgenic mouse model of the slow-channel syndromeC M Gomez, B B Bhattacharyya, P Charnet, et al.

Pageof 22